Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Bowel Ischemia / Infarction”

7 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 7 of 7 results

Post-approval studies (Phase 4)Looking for participantsNCT04416581
What this trial is testing

Potassium-Competitive Acid Blocker Versus pROton-Pump Inhibitor for GastroproTECTion Strategies In Patients at High Gastro-Intestinal Bleeding Risk Receiving Antithrombotic Therapy

Who this might be right for
Coronary Artery DiseasePercutaneous Coronary InterventionAcute Coronary Syndrome+1 more
Duk-Woo Park, MD 3,320
Post-approval studies (Phase 4)Not Yet RecruitingNCT07203846
What this trial is testing

Modulation of Gut MicroFLORA With Rifaximin to Reduce High Platelet Reactivity in Post-ACS Patients on Ticagrelor

Who this might be right for
ACS - Acute Coronary SyndromeTicagrelorMicrobiota+10 more
Collegium Medicum w Bydgoszczy 50
Large-scale testing (Phase 3)Ended earlyNCT00557921
What this trial is testing

Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1)

Who this might be right for
Acute Coronary SyndromeMyocardial InfarctionCoronary Artery Disease+1 more
Cogentus Pharmaceuticals 5,000
Not applicableLooking for participantsNCT06541691
What this trial is testing

Coated or Chewable Aspirin and a Hybrid Strategy to Mitigate Adverse Effects of Air Pollution in Stable Atherosclerotic Disease

Who this might be right for
Atherosclerotic Cardiovascular DiseaseCoronary Artery DiseaseIschemic Heart Disease+4 more
Rajaie Cardiovascular Medical and Research Center 3,000
Not applicableLooking for participantsNCT07429227
What this trial is testing

Evaluation Through Innovative Examinations of Intestinal Dysbiosis Status in Patients Diagnosed With Cardiovascular Diseases and Evaluation of the Efficacy of Natural and Probiotic Extracts in the Non-pharmacological Approach to Improving Intestinal Dysbiosis Status.

Who this might be right for
Acute Coronary Syndromes (ACS)
Casa di Cura Dott. Pederzoli 15
Testing effectiveness (Phase 2)Ended earlyNCT04433546
What this trial is testing

Pemziviptadil (PB1046), a Long-acting, Sustained Release Human VIP Analogue, Intended to Provide Clinical Improvement to Hospitalized COVID-19 Patients at High Risk for Rapid Clinical Deterioration and Acute Respiratory Distress Syndrome (ARDS).

Who this might be right for
Acute Respiratory Distress SyndromeCoronavirusHypoxic Respiratory Failure+15 more
PhaseBio Pharmaceuticals Inc. 54
Not applicableUnknownNCT04561323
What this trial is testing

Diagnosing Acute Onset Insufficient Intestinal Blood Flow (Bowel Ischemia) With a Novel CT Technique Called Dual-energy CT (DECT). This Observational Study Seeks to Evaluate Whether DECT Can Improve the Diagnosis of Bowel Ischemia and How the DECT Findings Correlate With Intraoperative Findings

Who this might be right for
Bowel IschemiaAcute Bowel Ischemia / Infarction
Rigshospitalet, Denmark 44